Company profilePharmaceutical#339 of 1,318 in Pakistan1 DRAP alert

AKHAI PHARMACEUTICALS.

Pharmaceutical company · 52 brands · 52 molecules

Ranked #18 of 74 companies in Pain Management

52 registered products 15 pharmaceutical brands 52 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

AKHAI PHARMACEUTICALS. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 52 product registrations across 52 distinct molecules. Its portfolio is concentrated in Pain Management and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by AKHAI

8 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 3

CampexpRs 128.6 PofolRs 2,318.55 Restane1mlRs 30.83

Opioids 2

CampexRs 551.4 Campex50mgRs 551.4

Neuro 2

Flucate25mgRs 146.3 FlucateRs 146.3

Anti-Infectives 1

Aclovainf250mgRs 3,231.75

Top molecules by brand count

Suxamethonium2 brands

Tramadol2 brands

Clobetasone2 brands

Thiocolchicoside1 brand

Cefixime1 brand

Azithromycin1 brand

Isoflurane1 brand

Dobutamine1 brand

Atracurium1 brand

Hydrocortisone1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO1 products · Rs 146.3 – Rs 146.3

Servaid8 products · Rs 30.83 – Rs 3,231.75

Median across source: Rs 576.85

Regulatory record

1 alert in the DRAP feed we track.

Rapid Alert: Drug Product; Falsified Restane Inhalational Solution Identified and Confisca

2022-12-01

Competitive set

Companies whose registered portfolio overlaps most with this one.

SHROOQ PHARMACEUTICALS22 shared molecules

GLOBAL BRANDS DISTRIBUTORS19 shared molecules

NEUTRO PHARMA (PVT) LTD.19 shared molecules

BIO LABS (PVT) LTD.17 shared molecules

SIZA INTERNATIONAL (PVT) LTD.17 shared molecules

Global Pharmaceuticals Pakistan16 shared molecules

MEDIATE PHARMACEUTICALS (PVT) LTD16 shared molecules

VALOR PHARMACEUTICALS16 shared molecules

MEDICEENA PHARMA (PVT) LTD.16 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD15 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio

GLOBAL BRANDS DISTRIBUTORS holds 5 molecules not in this portfolio

NEUTRO PHARMA (PVT) LTD. holds 125 molecules not in this portfolio

Get the full profile for AKHAI

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included